Lipopolysaccharide alterations responsible for combined quinolone and beta-lactam resistance in Pseudomonas aeruginosa.

Abstract:

:Resistant variants of three clinical Pseudomonas aeruginosa isolates were obtained in the presence of aztreonam. The variants exhibited a four- to eightfold increase in the minimal inhibitory concentrations to beta-lactam antibiotics (except imipenem) to quinolones, such as norfloxacin and fleroxacin, chloramphenicol and tetracycline, but not to gentamicin and polymyxin B. beta-Lactamase production was barely detectable in both wild-type strains and the resistant clones. Only ampicillin, cefoxitin and imipenem increased the production of beta-lactamase, whereas various other beta-lactams did not. Penicillin-binding proteins remained unchanged in the aztreonam-resistant clones. The analysis of the outer membrane proteins did not reveal differences in the outer membrane proteins between the wild-type strains and the aztreonam-resistant clones. Two of the three antibiotic-resistant isogenic clones contained less lipopolysaccharides (LPSs) than their corresponding wild-type strains. Moreover, it could be demonstrated that the ratio of 2-keto-3-deoxy octonate to carbohydrate of the LPS changed in any case between the wild-type strains and the aztreonam-resistant clones. These alterations were accompanied by a decrease in surface hydrophobicity of the resistant clones as compared to the wild-type strains. Therefore, quantitative as well as qualitative alterations in the LPS may provide an explanation for the resistant phenotype observed.

journal_name

Chemotherapy

journal_title

Chemotherapy

authors

Leying HJ,Büscher KH,Cullmann W,Then RL

doi

10.1159/000238946

subject

Has Abstract

pub_date

1992-01-01 00:00:00

pages

82-91

issue

2

eissn

0009-3157

issn

1421-9794

journal_volume

38

pub_type

杂志文章
  • Penetration of latamoxef, cefoperazone and piperacillin into the sputum of patients with cystic fibrosis.

    abstract::Concentrations of latamoxef, cefoperazone and piperacillin, administered intravenously, were measured in serum and sputum of cystic fibrosis patients with recurrent pulmonary infections, chronically colonized with Pseudomonas aeruginosa. Serum pharmacokinetic data were consistent with prior reports. Peak sputum to pea...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238344

    authors: Laferriere C,Stutman HR,Marks MI,Kramer J,Flux M

    更新日期:1985-01-01 00:00:00

  • Comparative pharmacokinetics of ceftriaxone after subcutaneous and intravenous administration.

    abstract::The pharmacokinetics of ceftriaxone (CRO) after subcutaneous and intravenous administration was studied in 10 healthy volunteers (5 males, 5 females, age 22-43 years, body weight 64.3 +/- 9.5 kg). Each of them received 2.0 g CRO i.v., and then 0.5 g i.v. and 0.5 g CRO s.c. in a randomized cross-over design. Subcutaneo...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238342

    authors: Borner K,Lode H,Hampel B,Pfeuffer M,Koeppe P

    更新日期:1985-01-01 00:00:00

  • Modulating effect of subinhibitory concentrations of compound LY 127935 on the virulence of Escherichia coli in the mouse.

    abstract::The filamentous forms of a serum resistant Escherichia coli strain developed under in vitro exposure to subminimal inhibitory concentration of the compound LY 127935 showed a higher resistance against host defence than the nontreated control bacteria. Significantly diminished LD50 values and a longer lasting persisten...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238068

    authors: Pusztai-Markos Z,Pranada F,Leimbrock C

    更新日期:1982-01-01 00:00:00

  • Susceptibility of Mycobacterium tuberculosis strains to gatifloxacin and moxifloxacin by different methods.

    abstract:BACKGROUND:Considering the potentials of gatifloxacin and moxifloxacin in the treatment of tuberculosis, the present study was aimed to define resistance to both these drugs. METHODS:Fifty Mycobacterium tuberculosis isolates, consisting of 30 ofloxacin-susceptible and 20 ofloxacin-resistant strains, were tested for th...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000093486

    authors: Somasundaram S,Paramasivan NC

    更新日期:2006-01-01 00:00:00

  • Pharmacokinetic study on adenomatous prostate tissue concentrations of cefoperazone. Clinical efficacy and patient tolerance of intramuscular cefoperazone treatment of chronic bacterial prostatitis.

    abstract::Cephalosporins do not reach active therapeutical concentrations in the prostatic tissue in patients suffering from chronic bacterial prostatitis. Cefoperazone is an exception. Its efficacy in the treatment of chronic bacterial prostatitis in 20 patients was studied and the concentrations, obtained after intramuscular ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238704

    authors: Melloni D,Ammatuna P,Formica P,Falletta V,Gaglio F,Cacciatore M,Messina G

    更新日期:1989-01-01 00:00:00

  • Pneumococcal meningitis-therapeutic studies in mice.

    abstract::A technique for inducing pneumococcal meningitis in mice and a description of the histopathologic changes that accompany this experimentally produced disease are provided in the present report. This infection of mice was investigated to determine whether it could serve as a suitable model for detecting agents that hav...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221879

    authors: Tsai YH,Williams EB,Hirth RS,Price KE

    更新日期:1975-01-01 00:00:00

  • Interaction of beta-lactam antibiotics with the penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae.

    abstract::The binding of five structurally diverse beta-lactam antibiotics to penicillin-binding proteins (PBPs) of two clinical isolates of Streptococcus pneumoniae resistant to penicillin G was compared with that of a susceptible strain. A common feature of the PBP patterns of the resistant strains was the absence of PBP 1a d...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000239338

    authors: Ikeda F,Yokota Y,Ikemoto A,Teratani N,Shimomura K,Kanno H

    更新日期:1995-05-01 00:00:00

  • A case of hemiballism as a rare side effect of ciprofloxacin in a patient with liver cirrhosis.

    abstract:BACKGROUND:Ciprofloxacin is commonly used and considered to be relatively safe in patients with cirrhosis, especially in the treatment of enteric and urinary tract infections. Among the adverse effects of ciprofloxacin, neurologic complications are rare. METHODS/RESULTS:We report a case of hemiballism and altered ment...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000218098

    authors: Kim SH,Jeong SH,Kim JW,Lee SH,Kim JM

    更新日期:2009-01-01 00:00:00

  • In vitro and in vivo studies of the action of rifampicin, clofazimine and B1912 on Mycobacterium marinum.

    abstract::Rifampicin (RMP) and two riminophenazine compounds (B663 and B1912) suppressed the growth of Mycobacterium marinum in vitro and in a mouse footpad infection. At appropriate concentrations and dietary dosage, all three drugs showed bactericidal activity in vitro and in vivo. On the basis of minimum inhibitory concentra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221931

    authors: Banerjee DK,Holmes IB

    更新日期:1976-01-01 00:00:00

  • A Novel Approach of Synthesizing and Evaluating the Anticancer Potential of Silver Oxide Nanoparticles in vitro.

    abstract:BACKGROUND:Development of novel strategies to kill cancer by sparing normal cells is of utmost importance. Apart from their known antimicrobial activity, only limited information has been recorded regarding the antitumor potential of biocompatible silver oxide nanoparticles (AgONPs). There is a need to evaluate the ant...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000453446

    authors: Banerjee K,Das S,Choudhury P,Ghosh S,Baral R,Choudhuri SK

    更新日期:2017-01-01 00:00:00

  • In vitro comparative dynamics of modified-release clarithromycin and of azithromycin.

    abstract::Antibacterial kinetics of modified-release clarithromycin (CLA) and azithromycin (AZI) against respiratory tract pathogens were compared in relation to their pharmacokinetic profile. The study was carried out in three strains of Streptococcus pneumoniae, group A beta-hemolytic Streptococcus pyogenes, Moraxella catarrh...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007308

    authors: Scaglione F,Demartini G,Dugnani S,Fraschini F

    更新日期:2000-09-01 00:00:00

  • In vitro antibacterial activity of imipenem in combination with newer quinolone derivatives.

    abstract::The antibacterial activity of imipenem combined with norfloxacin, ciprofloxacin, or ofloxacin against 43 gram-positive cocci and 53 aerobic gram-negative rods compared to results obtained with the combination of imipenem with amikacin. Synergistic antibacterial action (defined as FIC index less than or equal to 0.5) w...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238558

    authors: Kern W,Gulden H,Vanek E,Kurrle E

    更新日期:1988-01-01 00:00:00

  • In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid).

    abstract::The in vitro activities of quinupristin/dalfopristin (Synercid), ampicillin, erythromycin, clarithromycin, vancomycin, teicoplanin, ciprofloxacin and tetracycline were examined and compared against 526 gram-positive bacteria. The minimal inhibitory concentrations (MICs) for quinupristin/dalfopristin against Staphyloco...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000048530

    authors: Ling TK,Fung KS,Cheng AF

    更新日期:2001-07-01 00:00:00

  • Fluoropyrimidine-Associated Toxicity in Two Gastrointestinal Cancer Patients: Potential Role of Common DPYD Polymorphisms.

    abstract::While the majority of patients can be treated safely with fluoropyrimidine, some experience severe fluoropyrimidine-associated toxicity. The frequency and severity of these adverse events vary from patient to patient and are partially explained by genetic polymorphism into the dihydropyrimidine dehydrogenase (DPYD) ge...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000477333

    authors: Falvella FS,Luoni M,Cheli S,Fava S,Cergnul M

    更新日期:2017-01-01 00:00:00

  • Comparative randomized pilot study of azithromycin and doxycycline efficacy and tolerability in the treatment of prostate infection caused by Ureaplasma urealyticum.

    abstract::A total of 1,442 patients with symptoms of chronic prostatitis were examined over a 4-year period at the Outpatient Department for Urogenital Infections, University Hospital for Infectious Diseases Dr. Fran Mihaljević, Zagreb, Croatia. The inclusion criteria for chronic prostatitis caused by Ureaplasma urealyticum wer...

    journal_title:Chemotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1159/000090234

    authors: Skerk V,Mareković I,Markovinović L,Begovac J,Skerk V,Barsić N,Majdak-Gluhinić V

    更新日期:2006-01-01 00:00:00

  • The value of tumor markers in evaluating chemotherapy response and prognosis in Chinese patients with advanced non-small cell lung cancer.

    abstract:OBJECTIVE:The aim of this study was to assess the value of tumor markers in monitoring chemotherapy response and predicting prognosis in patients with advanced non-small cell lung cancer (NSCLC). METHODS:We studied carcinoembryonic antigen (CEA), CYFRA21-1 and neuron-specific enolase (NSE) of 111 untreated patients wi...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000317580

    authors: Jin B,Huang AM,Zhong RB,Han BH

    更新日期:2010-01-01 00:00:00

  • Antiviral activity of a pyrazino-pyrazine derivative.

    abstract::The 2,3-dihydroxy-6-bromo-pyrazino-[2,3-beta]-pyrazine is a substance selected during the antiviral screening of pyrazino-pyrazine derivatives. The compound shows antiviral activity in vitro against measles, NDV, some influenza viruses and against herpes simplex and zoster, infectious canine hepatitis and vaccinia vir...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000221862

    authors: Verini MA,Fioretti A,Casazza AM,Sanfilippo A,Palamidessi G,Ghione M

    更新日期:1975-01-01 00:00:00

  • In vitro synergy studies using aztreonam and fluoroquinolone combinations against six species of Gram-negative bacilli.

    abstract:BACKGROUND:Combination antimicrobial therapy is often necessary to eradicate infections caused by gram-negative bacteria. METHODS:To evaluate the potential benefit of aztreonam and fluoroquinolone combination therapy, the activity of aztreonam in combination with ciprofloxacin, gatifloxacin, levofloxacin and moxifloxa...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000069786

    authors: Critchley IA,Sahm DF,Kelly LJ,Karlowsky JA

    更新日期:2003-05-01 00:00:00

  • Nevirapine toxicity in non-HIV cancer patients.

    abstract:BACKGROUND:Nevirapine (NVP) is a nonnucleoside reverse transcriptase inhibitor used in HIV patients and recently evaluated as a differentiating and antiproliferative agent in human malignancies. However, while NVP is a safe treatment in immunocompromised patients, NVP-containing regimens have been associated with sever...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1159/000159273

    authors: Landriscina M,Fabiano A,Lombardi V,Santodirocco M,Piscazzi A,Fersini A,De Vis K,Barone C,Cignarelli M

    更新日期:2008-01-01 00:00:00

  • Treatment of experimental ascending Escherichia coli pyelonephritis with ceftriaxone alone and in combination with gentamicin.

    abstract::We have tested the effectiveness of several antibiotic regimens, using a rat model of Escherichia coli experimental pyelonephritis that mimics the conditions of severe renal infections in man because the infection is acquired by the ascending route. We found that ceftriaxone, when given for 5 days to rats with severe ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238130

    authors: Glauser MP,Bonard

    更新日期:1982-01-01 00:00:00

  • Correlations between thymidylate synthase expression and chemosensitivity to 5-fluorouracil, cell proliferation and clinical outcome in head and neck squamous cell carcinoma.

    abstract:BACKGROUND:5-Fluorouracil (5-FU) is a widely used drug in head and neck squamous cell carcinoma (HNSCC). Thymidylate synthase (TS), which is the target enzyme of 5-FU, has been demonstrated to be a key regulatory enzyme. In this study, we examined whether TS expression is correlated with chemosensitivity to 5-FU, cell ...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000175465

    authors: Yasumatsu R,Nakashima T,Uryu H,Ayada T,Wakasaki T,Kogo R,Masuda M,Fukushima M,Komune S

    更新日期:2009-01-01 00:00:00

  • In vitro AN69 and polysulphone membrane permeability to ceftazidime and in vivo pharmacokinetics during continuous renal replacement therapies.

    abstract:BACKGROUND:Ceftazidime is a third-generation cephalosporin almost entirely eliminated by glomerular filtration and dose reductions are essential in patients with renal impairment. The physicochemical and pharmacokinetic properties of ceftazidime make it susceptible to be eliminated by continuous renal replacement thera...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1159/000100864

    authors: Isla A,Gascón AR,Maynar J,Arzuaga A,Sánchez-Izquierdo JA,Pedraz JL

    更新日期:2007-01-01 00:00:00

  • Influence of dosage interval on the therapeutic response to gentamicin in mice infected with Klebsiella pneumoniae.

    abstract::Without treatment all mice died after receiving 10(3) Klebsiella pneumoniae by intraperitoneal injection. Nevertheless, it was possible to delay treatment for 12 h and still observe a therapeutic response from im gentamicin (5 mg/kg). This gave initial serum concentrations comparable to clinical levels, which fell rap...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238477

    authors: Queiroz ML,Bathirunathan N,Mawer GE

    更新日期:1987-01-01 00:00:00

  • Adenosylmethionine decarboxylase inhibitors--lack of activity against cytopathic effects of HIV.

    abstract::Many bis(amidinohydrazones) are potent inhibitors of adenosylmethionine decarboxylase (AdoMetDC), a key enzyme of polyamine biosynthesis, and some of them are also known to be powerful antiviral agents. Therefore, seven bis(amidinohydrazones), including the two most potent inhibitors of eukaryotic AdoMetDC so far repo...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238790

    authors: Elo H

    更新日期:1990-01-01 00:00:00

  • Management of Ponatinib in Patients with Chronic Myeloid Leukemia with Cardiovascular Risk Factors.

    abstract::Cardiovascular (CV) adverse events are considered common complications of ponatinib treatment. Recently, it has been demonstrated that ponatinib dose reductions in definite settings can obtain optimal responses and lower ponatinib-related CV events. In this study, we describe the management of 5 patients with chronic ...

    journal_title:Chemotherapy

    pub_type:

    doi:10.1159/000504664

    authors: Santoro M,Accurso V,Mancuso S,Contrino AD,Sardo M,Novo G,Di Piazza F,Perez A,Russo A,Siragusa S

    更新日期:2019-01-01 00:00:00

  • Effects of platinum antitumor agents on in vitro assays of human antitumor immunity. II. Effects of cis-[Pt(NH3)2Cl2] on spontaneous cell-mediated cytotoxicity.

    abstract::The effects of cis-[Pt(NH3)2Cl2] on the spontaneous cell-mediated cytotoxicity of human lymphoblast cell lines mediated by normal human peripheral blood lymphocytes was investigated. Direct addition of cis-[Pt(NH3)2Cl2], but not its tumor inactive trans isomer, to the in vitro spontaneous cytotoxicity assay resulted i...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000237876

    authors: Mally MB,Taylor RC,Callewaert DM

    更新日期:1980-01-01 00:00:00

  • Comparison of aztreonam plus clindamycin with tobramycin plus clindamycin in the treatment of intra-abdominal infections.

    abstract::The activity of aztreonam (a beta-lactam antibiotic with specific activity against gram-negative bacteria) was evaluated and compared with that of tobramycin in hospitalized patients with severe intra-abdominal infections due to gram-negative pathogens, either alone or in association with other bacteria. Of a total st...

    journal_title:Chemotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1159/000238721

    authors: Birolini D,Moraes MF,de Souza OS

    更新日期:1989-01-01 00:00:00

  • Biliary excretion of cefaclor. Experimental and clinical study.

    abstract::Biliary excretion of cefaclor, a new orally active cephalosporin, was studied in vitro using an isolated rabbit liver preparation perfused for 3 h (n = 5). Under these conditions, bile recovery amounted to 2.3% of the cefaclor dose added to the circulating blood (10 mg). In humans, after oral administration of a 1-gra...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000238075

    authors: Brogard JM,Pinget M,Comte F,Adloff M,Lavillaureix J

    更新日期:1982-01-01 00:00:00

  • In vitro and in vivo antibacterial activities of AM-1155 in the fields of obstetrics and gynecology.

    abstract::AM-1155 is a new 8-methoxyquinolonecarboxylic acid with a broad spectrum of antibacterial activity. It inhibited more than 90% of clinical isolates of Streptococcus agalactiae, Escherichia coli, Peptostreptococcus magnus, Bacteroides fragilis and Prevotella bivia at the concentration of 3.13 mg/l. The antibacterial ac...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000007120

    authors: Mikamo H,Kawazoe K,Sato Y,Hayasaki Y,Izumi K,Tamaya T

    更新日期:1998-07-01 00:00:00

  • Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.

    abstract:BACKGROUND:The aim of this clinical study was to evaluate the efficacy of combination chemotherapy of oxaliplatin, leucovorin and continuous-infusion 5-fluorouracil (5-FU) for advanced gastric cancer. METHODS:Patients with previously untreated gastric cancer with measurable disease received oxaliplatin (100 mg/m(2), d...

    journal_title:Chemotherapy

    pub_type: 杂志文章

    doi:10.1159/000219434

    authors: Lim JY,Cho JY,Oh KJ,Choi SH,Lee SI,Jeung HC

    更新日期:2009-01-01 00:00:00